Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Types of Pancreatic Cancer: Causes, Treatment & Prognosis.
Types of Pancreatic Cancer: Causes, Treatment & Prognosis. 4

Getting a diagnosis is a big change that needs clear and caring help. We know how hard this news is for you and your family. We aim to give you the support to face this journey with confidence.

Pancreatic cancer is not just one disease. It’s a group of different types of pancreatic cancer. These cancers start in the glandular tissues and each has its own special features. Knowing which type you have is key to getting the right treatment.

Knowing about these pancreatic cancer types helps our doctors create a plan just for you. At Liv Hospital, we mix proven methods with a plan that fits you. We’re committed to giving you the best care and making sure you get the right treatment.

Key Takeaways

  • Pancreatic malignancies are diverse, requiring specialized diagnostic approaches.
  • Early identification of the specific tumor variant is vital for successful outcomes.
  • Treatment plans must be personalized based on unique biological characteristics.
  • Liv Hospital offers thorough evaluations to help with your healthcare choices.
  • Compassionate support is as important as advanced medical care.

Understanding the Different Types of Pancreatic Cancer

Understanding the Different Types of Pancreatic Cancer
Types of Pancreatic Cancer: Causes, Treatment & Prognosis. 5

The pancreas is home to several types of cancer. Many people ask, are there different types of pancreatic cancer? Yes, there are. Knowing the pancreatic tumors types is key because each type needs a special treatment plan.

We sort these cancers by where they start in the pancreas. Knowing how many types of pancreatic cancer are there helps doctors plan your treatment. By identifying the types of pancreatic tumors, we can guess how the disease will grow.

Exocrine Pancreatic Tumors: The Most Common Forms

Most cases are exocrine pancreatic cancer. These tumors grow in the cells that make digestive enzymes. When we talk about what are types of pancreatic cancer, we focus on these, which make up about 92% of cases.

The most common type of pancreatic cancer is pancreatic adenocarcinoma. You might ask, what is pancreatic adenocarcinoma? It’s a cancer that starts in the ductal cells and makes up about 90% of exocrine cases. Though it’s the most common, other types of pancreatic cancers exist, like acinar cell carcinoma and colloid carcinomas.

These pancreatic types act differently. For example, colloid carcinomas might have a better outlook than standard adenocarcinoma. Knowing these different types of pancreatic cancer lets us tailor treatments to fit your tumor’s specific needs.

Neuroendocrine Pancreatic Tumors: A Distinct Category

Though exocrine tumors are more common, neuroendocrine pancreatic tumors (NETs) are also important. They start in the hormone-producing islet cells and make up about 8% of cases. They need a different approach for diagnosis and treatment.

Tumor CategoryPrevalencePrimary Origin
Exocrine (Adenocarcinoma)~83%Ductal Cells
Exocrine (Other)~9%Acinar/Ductal Cells
Neuroendocrine (NETs)~8%Islet Cells

Because these tumors come from hormone-producing cells, they can cause unique symptoms. Our team works to understand these symptoms to give you the best care. We aim to provide clear information and support as we tackle these complex medical issues together.

Clinical Characteristics, Treatment Approaches, and Prognosis

Clinical Characteristics, Treatment Approaches, and Prognosis
Types of Pancreatic Cancer: Causes, Treatment & Prognosis. 6

Understanding pancreatic health is complex. We know how tumors behave and how they react to treatments. Getting a diagnosis can be tough, but we’re here to help. We use the latest technology and care with compassion to help our patients.

Diagnostic Challenges and Early Detection

The pancreatic tumor often hides in its early stages. This makes finding it early hard. It’s deep in the abdomen, so symptoms show up late.

Early detection is key. It can raise the five-year survival rate to about 20%. We use advanced imaging and tests to find tumors early.

Standard Treatment Modalities for Pancreatic Malignancies

Treating adenocarcinoma pancreatic cancer needs a team effort. Our experts create a treatment plan that might include surgery, chemo, or targeted therapies. We aim to remove the tumor while keeping the patient’s quality of life good.

Surgery is often the first choice for tumors that can be removed. After surgery, we might use chemo or other treatments to kill any cancer cells left. This approach attacks the cancer from all sides to give the best care.

Prognostic Outlook and Survival Rates

The outlook for adenocarcinoma pancreatic is tough. The five-year survival rate is about 9% worldwide. But we keep looking for new treatments to help our patients.

The worst type of pancreatic cancer is aggressive and often found late. But, new treatments like immunotherapy and precision medicine are making a difference. We believe informed patients can face their treatment journey with hope.

Treatment StagePrimary GoalCommon Modality
Early DetectionSurgical RemovalResection Surgery
Advanced StageSymptom ManagementChemotherapy
Recurrent CaseDisease ControlTargeted Therapy

Conclusion

Understanding your diagnosis is key. We know how tough it is to find out about tumours in the pancreas. Our goal is to help you with clear information and expert advice every step of the way.

Medical science is always getting better, thanks to new research in oncology. This means there’s hope for better treatment options for pancreatic tumors. Keep up with these advances and talk to your doctors about them.

Your health is the main thing we think about. We want you to talk openly with your doctors. This way, you can get a treatment plan that really works for you.

We’re here to help patients from around the world who need special care. Contact our team to talk about your situation and what options you have. Taking action now can help your health a lot in the future.

FAQ

Are there different types of pancreatic cancer, and how many types of pancreatic cancer are there in total?

Yes, there are different types of pancreatic cancer. Broadly, pancreatic cancers are divided into two main categories: exocrine tumors and neuroendocrine tumors. Exocrine tumors are the most common, while neuroendocrine tumors are less common but behave differently. Within these categories, there are several subtypes, so overall there are multiple distinct forms rather than a single uniform disease.

What is the most common type of pancreatic cancer diagnosed today?

The most common type is pancreatic ductal adenocarcinoma. It accounts for the majority of pancreatic cancer cases and arises from the ducts that carry digestive enzymes. This type is usually more aggressive and is often diagnosed at a later stage.

What are types of pancreatic cancer classified as exocrine versus neuroendocrine?

Exocrine pancreatic cancers include pancreatic ductal adenocarcinoma, acinar cell carcinoma, and other rare ductal tumors. Neuroendocrine tumors arise from hormone-producing cells in the pancreas and include functioning and non-functioning pancreatic neuroendocrine tumors. These two groups differ in behavior, growth rate, and treatment response.

What is the worst type of pancreatic cancer regarding prognosis and survival?

Pancreatic ductal adenocarcinoma is generally considered the most aggressive and has the poorest prognosis among common pancreatic cancers. It tends to spread early, is often diagnosed late, and is less responsive to treatment compared to many other tumor types.

How do we treat the various types of pancreatic tumors?

Treatment depends on the type and stage. For exocrine tumors like pancreatic ductal adenocarcinoma, treatment often includes surgery if possible, followed by chemotherapy and sometimes radiation therapy. For pancreatic neuroendocrine tumors, surgery is also used when feasible, along with targeted therapies, hormone control treatments, and chemotherapy in more advanced cases. Treatment is always tailored based on tumor behavior and spread.

Are the symptoms different for various types of pancreatic cancer?

Symptoms can be similar across different types, especially in early stages, such as abdominal pain, weight loss, jaundice, and digestive problems. However, neuroendocrine tumors may sometimes produce hormone-related symptoms like low blood sugar, flushing, or diarrhea, depending on the hormones involved, while exocrine tumors more commonly present with obstructive and digestive symptoms.

References

Nature. https://www.nature.com/articles/nrdp201622

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91